Crohn’s Disease Market Growing Developments and Progressions In Treatments Foreseen by 2022 | Along With Top Key Players

May 9, 2019

Crohn’s Disease Market report by Market Research Future explores Scope of the Study to expect growth at 3% CAGR During 2019-2022. Global Crohn’s Disease Market Information by Procedures (Colonoscopy, Flexible Sigmoidoscopy, Computerized Tomography (CT), Capsule Endoscopy, Double-Balloon Endoscopy, Small Bowel Imaging), by Drugs.

Pune, Maharashtra - May 9, 2019 /MarketersMedia/ —

Global Crohn’s Disease Market has been evaluated as growing market and expected that the market will reach high growth figures in the coming future. Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune and bacterial factors in genetically prone individuals. There are no medications, drugs or surgical procedures that can cure or prevent Crohn's disease. It is expected that the disease affects about 3.2 per 1,000 people in Europe and North America. It is less common in Asia and Africa. Rates have, however, been growing, particularly in the developing world, since last few years.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2344

Major factors leading to the growth of the market includes higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R&D programs. High cost of treatment and lack of early diagnosis techniques are the major factor restricting the market growth.

Global Crohn’s Disease Market - Key Players

Key players profiled in the report are

Allergan, Inc.
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Bayer AG
UCB S.A.
Perrigo Company plc.
Pfizer Inc.
Johnson & Johnson Services, Inc.
Ferring B.V.

Crohn’s Disease Market – Segmentation

Global Crohn’s Disease Market is segmented in to 3 Key dynamics for an easy grasp and enhanced understanding.

By Procedures: Comprises - Colonoscopy, Flexible Sigmoidoscopy, Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), Capsule Endoscopy, and Small Bowel Imaging & Double-Balloon Endoscopy among others.

By Drug Types: Anti-Diarrheal, Antibiotics, Immune System Suppressors, Anti-Inflammatory Drugs Pain Relievers among others.

By Regions: North America, Europe, APAC and Rest of the World.

Global Crohn’s Disease Market – Regional Analysis

North America accounts for the largest market share of the global Crohn’s Disease Market followed by the Europe & Asia Pacific regions. The North America market is growing due to the largest contribution from the significantly growing market of the US.

On the other hand, growth of the world’s second largest market for Crohn’s Disease, (Europe) is driven by the higher per capita income and strong healthcare penetration in the region.

While Asia Pacific Crohn’s Disease Market is expected to perceive an exponential growth. The market growth will be led by China and India owing to the huge population and the low cost of Crohn’s drugs.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/press-release/crohns-disease-market

Source URL: https://marketersmedia.com/crohns-disease-market-growing-developments-and-progressions-in-treatments-foreseen-by-2022-along-with-top-key-players/510688

Source: MarketersMedia

Release ID: 510688

More News

Oct 29, 2026

Injuries hamper start of NBA season

IF things go the way Anthony Edwards and the Minnesota Timberwolves currently envision, he’ll be back from arthroscopic knee surgery in plenty of time for a playoff push and possibly making a run at winning an NBA championship. In other words, his injury could have been worse. Edwards is out of Minnesota’s lineup for the foreseeable future, since the long-term goal — a title — obviously is far more important than anything like the individual awards that he won’t be eligible to win this season because he’ll miss too many games. He was playing in pain. His knee was only going to keep hurting. The decision was clear and fixing it now is the smart move. “It was kind of a bit of a shock to everybody last night, certainly unexpected at that point,” Timberwolves coach Chris Finch said Wednesday night. “The guys are pretty resilient. They came in in a pretty good mood today. Obviously, we talked a little bit about it, what it might mean for us going forward. ... Certainly, guys are disappointed for him and us. But, nothing you can do.” Edwards will be back with plenty of season left. Some teams don’t have that to lean on right now. Oklahoma City star Jalen Williams’ horrific leg and ankle injuries could only be repaired by surgery that may be season-ending, and Thunder teammate Cason Wallace is looking at a similar long road back after shoulder surgery. Both got hurt Sunday night, creating serious early season angst for a team that was widely expected to contend for a second championship in three years. Williams had surgery Wednesday in New York to fix the broken leg and reconstruct ankle ligaments. But — in perhaps a glimmer of hope — the Thunder said “Williams will be re-evaluated prior to the end of the 2026-27 regular season.” “We have a unique experience with this. It’s not something you want to have a lot of experience with, but we do,” Thunder general manager Sam Presti said, noting that Oklahoma City has not had the best luck in recent years when it comes to injuries. “I think we’ll probably lean on some of that. Then a large portion of it is we’re very process-oriented. I think it keeps you humble in good times and keeps you stable when you’re going through some adversity.” And adversity clearly has hit Oklahoma City, Minnesota and a few other places. Toronto will be without Kawhi Leonard for at least a week, probably more, because of knee swelling. Given his injury history, any mention of “Leonard” and “knee” in the same sentence likely sends chills down the spines of Raptors fans. The good news is that the Raptors say there’s no acute left knee injury causing the problem. The bad news is, well, there’s a problem. “Part of the game,” Toronto’s RJ Barrett said. “Obviously we wish everybody could play every game, but injuries are part of the game. That’s why you have a whole team. ... Until he gets back, we’ve got to figure it out.” Orlando is already down two players, with Paolo Banchero out for perhaps a month with a high ankle sprain and Jalen Suggs out with a knee issue that will sideline him for a couple of weeks — although when he got hurt, the initial fear was that it could have been something far more serious. Utah, a team that hopes to reenter the playoff chase for the first time in years, just lost center Jaren Jackson Jr. for perhaps two months with a torn knee ligament. Indiana — which didn’t have star guard Tyrese Haliburton last season because of a torn Achilles suffered in Game 7 of the 2025 NBA Finals — is bracing for him to be limited again, at least for a while, with what the team called a mild left hamstring strain. “Let’s just say, two weeks from now, if you guys want to ask how he’s doing, that’ll be fine,” Pacers coach Rick Carlisle said. “I don’t think it’s realistic that he would play before then. And then we’ll go from there. There’s a chance he could play in that period of time. It is mild. But it is a hamstring. And so, we’ll be cautious with it. It’s not good news but it could be worse.” All is not lost. But especially in what many believe could be very tight playoff races by season’s end, no team wants to be without its stars for too long. “It’s very early in the season,” Banchero said. “There’s a lot out in front of us.” He’ll be back. So, too, will Edwards. Leonard could be playing before long. They’re fortunate compared with many; Sacramento’s Ben Simmons blew out his Achilles tendon before the season even started and will miss another year, Golden State’s Kristaps Porzingis is away from the team while dealing with a health issue and a few other players — such as the Warriors’ Jimmy Butler III and the Timberwolves’ Donte DiVincenzo — are still sidelined while dealing with major injuries suffered last season. Losing Edwards is a tough blow to Minnesota. It likely will cost the Timberwolves some wins in November and December. But if it leads to wins in May and June, whatever struggles happen now surely will be deemed worthwhile.

Oct 29, 2026

Heat earn first win of NBA season

LOS ANGELES — The Miami Heat finally earned their first win since the start of the season and the arrival of superstar Giannis Antetokounmpo, defeating the Atlanta Hawks, 129-117, on Wednesday (Thursday in Manila). The Greek two-time NBA Most Valuable Player had been expected to immediately propel Miami into the ranks of Eastern Conference contenders, but his first victory in a Heat uniform came at the fifth time of asking. Antetokounmpo, who had a triple-double in defeat to the Dallas Mavericks two nights earlier, again racked up impressive numbers, with 24 points and 18 rebounds. This time he was backed up by teammates Bam Adebayo, who scored 24 with nine rebounds, and Andrew Wiggins who added 18 points. Former Milwaukee Bucks star Antetokounmpo reached 1,000 career steals while Adebayo became the Heat’s all-time leading rebounder, surpassing the record of 5,791 previously held by Udonis Haslem. The star-packed Philadelphia 76ers bounced back from Sunday’s disappointing loss against Detroit to move to 4-1 with victory in a back-and-forth clash with the Indiana Pacers. The new home of LeBron James struggled to see off Indiana, which this week announced it would be without star Tyrese Haliburton for around two weeks due to a hamstring injury. The Sixers fell behind in a lop-sided third quarter, but rallied down the final stretch to seal a road victory. Tyrese Maxey scored 17 of his 27 points in a blistering fourth quarter showing to spare his team’s blushes. James managed just 13 points but added 10 assists, while Joel Embiid had 21 points and 11 rebounds, and Jaylen Brown provided 20 points. AJ Dybantsa, the top overall pick of the recent NBA Draft, played his first NBA minutes during the Washington Wizards’ 121-111 loss to the Cleveland Cavaliers. Nineteen-year-old Dybantsa had missed the Wizards’ first four games with an ankle sprain but started Wednesday, scoring 19 points. The Cavaliers clinched victory in the final quarter. Donovan Mitchell scored 19 points with seven assists.